[1]
R. Perumal, K. Naidoo, A. Naidoo, and N. Padayatchi, “Clinical impact of plasma concentrations of first-line antituberculosis drugs”, S Afr Med J, vol. 113, no. 3, pp. 148–153, Mar. 2023, doi: 10.7196/SAMJ.2023.v113i3.16761.